Antibody Cocktails Market are proteins produced by immune cells that have a certain form and size that allows them to adhere to a specific location on a foreign material, such as a virus or bacteria. By adhering, the Antibody Cocktails Market may be able to prevent infection from these invaders. An antibody cocktail is a treatment that combines two antibodies, which are proteins produced by the body to defend or protect itself against disease. For example, a monoclonal antibody cocktail containing the antibodies Casirivimab and Imdevmab has shown to be effective in treating COVID-19 infection.
The high cost of pharmaceuticals and tight government requirements for product approval are two significant factors impeding the worldwide antibody cocktail market's growth. For example, Regeneron Pharmaceuticals Inc.'s REGEN-COV (Casrivimab and Imdevimab) antibody cocktail therapy is priced at US$ 2,100 per dosage in the United States, US$ 2,000 per dose in Germany, and US$ 820 per dose in India.
Read More @ https://cmiinfonest.blogspot.com/2022/05/antibody-cocktails-market-industry.html
